国际标准期刊号: 2376-127X

妊娠与儿童健康杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 学术钥匙
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Effect of Oral supplementation with Iron Sulphate (with Liposomal Vitamin C) in pregnant women to prevent Postpartum hemorrhage

Objective: to evaluate the impact of Oral Supplementation with iron sulphate (with liposomal vitamin C) in pregnant women to treat iron deficiency anemia.
Methods: This was an observational retrospective study. Women who received oral supplementation with oral iron sulphate (with liposomal vitamin C) as treatment for iron deficiency anemia were compared with women who did not. Inclusion criteria were singleton gestations with microcytic mild iron deficiency anemia. Mild anemia was defined as Hgb level between 9.00 and 10.99 g/dL. The primary outcome of the study was the incidence of anemia after treatment. The secondary outcomes were rise in serum ferritin, rise in Hgb level and maternal tolerability.
Results: 200 women, 100 for each group, were included in the study. Women who received the intervention had a significantly lower overall incidence of anemia after 2 months, and at post-partum follow-up visit. Moreover, rise in Hgb level and serum ferritin were significantly higher in the intervention.
Conclusion: Our retrospective cohort of singleton gestations with mild anemia in pregnancy showed that oral supplementation with iron sulphate (with liposomal vitamin C) as treatment for iron deficiency anemia was a safe and efficacy treatment to reduce the recurrence of anemia.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。